Valvular heart disease is a major cause of morbidity and mortality worldwide. Surgical valve
repair or replacement has been the standard of care for patients with valvular heart disease …

Background: In patients with severe aortic stenosis (AS) at intermediate surgical risk,
treatment with transcatheter aortic valve replacement (TAVR) or surgical aortic valve …

Objective The scope of this systematic review is to update the existing body of evidence
regarding the cost-effectiveness of transcatheter aortic valve implantation, stratified across …

Aims The economic value of transcatheter aortic valve replacement (TAVR) in low surgical
risk patients with severe, symptomatic aortic stenosis is not known. Our objective was to …

Background Recent studies have shown that transcatheter aortic valve implantation (TAVI) is
non-inferior to surgical aortic valve replacement (SAVR) for treatment of low-risk patients …

Objective: Transcatheter aortic valve implantation (TAVI) has become the therapy of choice
for treating severe aortic stenosis in patients at high-risk for surgery or where it is considered …

Background A recent clinical trial showed that self-expandable transcatheter aortic valve
replacement (TAVR) was non-inferior to surgical aortic valve replacement (SAVR). However …

Background: The number of patients treated for aortic valve disease in the United States is
increasing rapidly. Transcatheter aortic valve replacement (TAVR) is supplanting surgical …

Background and objectives: The treatment of severe aortic stenosis requires replacement of
the defective native valve. Traditionally, this has been done via surgery, but in the last 10 …

Abstract Background The recent PARTNER S3i trial compared transcatheter aortic valve
implantation (TAVI) using the third-generation SAPIEN 3 device to surgical aortic valve …